Exisulind
Names | |
---|---|
Preferred IUPAC name
[(1Z)-5-Fluoro-1-{[4-(methanesulfanyl)phenyl]methylidene}-2-methyl-1H-inden-3-yl]acetic acid | |
Other names
Sulindac sulfone, Aptosyn, FGN-1, Prevatac
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C20H17FO4S | |
Molar mass | 372.41 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Exisulind (tentative trade name Aptosyn) is an
COX-2 inhibition, p53, Bcl-2, or cell cycle arrest. Preclinical evidence suggests that exisulind also inhibits angiogenesis.[4]
See also
References